1. Introduction {#s0005}
===============

The restless legs syndrome (RLS) is a sensory-motor disorder causing a strong urge to move when staying at rest, especially in the evening and at night. In spite of the circadian variation of sensory and motor symptoms with increasing severity at night, potential associated diurnal changes of cognitive performance have not yet been investigated in RLS patients. RLS is strongly associated with a dopaminergic dysregulation and low doses of dopamine agents effectively reduce RLS symptoms ([@bb0020], [@bb0105], [@bb0125], [@bb0160], [@bb0225], [@bb0460], [@bb0455]). Taking into account that dopamine plays an important role in both motor ([@bb0005]) and cognitive functions ([@bb0335]), RLS patients should presumably also suffer from cognitive dysfunction. By means of various neuropsychological tests, cognitive deficits of RLS patients in the domains of attention, verbal fluency, and executive function have been shown in previous studies ([@bb0190], [@bb0195], [@bb0350]). Given that dopamine acts as a part of the circadian timing system ([@bb0150], [@bb0210], [@bb0265], [@bb0490], [@bb0505]), cognitive deficits of RLS patients may also vary with the time of the day. Based on the circadian pattern of motor symptoms, we assume that RLS patients have enhanced cognitive dysfunctions in the evening as compared to the morning. Cognitive processes such as selective attention, cognitive control, and response selection, are strongly modulated by dopamine ([@bb0175], [@bb0335], [@bb0390], [@bb0395], [@bb0530], [@bb0535]) and may therefore be vulnerable to the changed dopaminergic circadian rhythms in RLS patients ([@bb0155], [@bb0205]) and consequentially show strong timing effects/fluctuations during the day. To test this hypothesis, merely applying standard neuropsychological tasks would be problematic as it would remain unclear which underlying neurophysiological mechanisms are impaired in RLS patients. EEG and event-related potentials (ERPs) provide an excellent approach to this problem. Using EEG, Jung et al. ([@bb0250]) found attentional dysfunction in RLS patients compared to healthy controls, but this study did not provide insights into the underlying functional neuroanatomical structures and no hints for possible circadian effects.

The aim of the current study was to determine which cognitive neurophysiological sub-processes within the cascade from early attentional stimulus processing to response selection mechanisms are modulated by the disease-relevant circadian rhythm of RLS patients and which functional neuroanatomical networks contribute to this daytime effect.

Therefore, we combined EEG with source localization techniques (i.e., sLORETA) and examined daytime effects (morning vs evening) on cognitive functions in RLS patients compared to healthy controls. Dopamine-regulated cognitive processes such as selective attention, conflict monitoring and response selection can be examined by means of a flanker task ([@bb0170], [@bb0535]). The flanker task has been proved to be well-suited to investigate dopamine-related cognitive functions ([@bb0060], [@bb0065], [@bb0075], [@bb0080]). Here, selective attentional processing is necessary to select task-relevant information and to suppress distracting information ([@bb0060], [@bb0100]). As conflict arises in the condition with distracting information, effective conflict monitoring is required for correct response selection as the response tendencies caused by flankers need to be suppressed ([@bb0165], [@bb0385], [@bb0535]). Previous studies have reported that Parkinson patients, who also suffer from dopaminergic dysfunctions, showed an increased flanker interference effect ([@bb0370], [@bb0375], [@bb0515], [@bb0535]). This suggests that RLS patients should also show increased interference effects and that this impairment should be stronger in the evening.

An increased impairment in attentional selection reflected by the N1 ERP ([@bb0070], [@bb0230], [@bb0235], [@bb0290], [@bb0405]) as well as later cognitive processes such as conflict monitoring reflected by the N2 ([@bb0180], [@bb0280], [@bb0450]) and stimulus-response mapping reflected by the P3 ([@bb0480]) might be found among RLS patients in the evening. Furthermore, a reduced D2 receptor binding has been found in RLS patients ([@bb0305], [@bb0430], [@bb0435], [@bb0440], [@bb0465]). As D2 autoreceptors are especially sensitive in the evening ([@bb0150]) and blockade of D2 receptors reduces acetylcholine efflux ([@bb0310]), a reduced D2 receptor binding in RLS patients can exert a strong influence on acetylcholine distribution in the evening. Since cholinergic activity directly contributes to the modification of receptive field properties or the suppression of contextual information, a marked impact on early attentional processes reflected by P1 and N1 may be evident in RLS patients. Apart from this, the extension of the dopaminergic cortical innervation in the rostro-caudal direction is related to the cognitive capacities such as sensorimotor integration ([@bb0335]) and this anterior-posterior communication is impaired in RLS patients ([@bb0115]). Based thereon, the early attentional processes which are associated with posterior areas are likely to be more severely concerned than cognitive processes, which are related to frontal areas.

2. Methods {#s0010}
==========

2.1. Patients and controls {#s0015}
--------------------------

*N* = 33 adult patients with a stable medication treatment for at least 4 weeks were recruited from the Sleep disorders outpatient clinic of the Department of Neurology, Carl Gustav Carus University hospital in Dresden, Germany. The patients had a confirmed RLS diagnosis based on the International Restless Legs Syndrome Study Group (IRLSSG) diagnostic criteria ([@bb0030]) and showed no other neurological or psychiatric diseases. *N* = 33 individually age- (± 3 years) and gender-matched healthy control participants were recruited for comparison with the RLS patients. The control group was free of any neurological or psychiatric diseases. Patients and controls were tested in the morning (beginning between 8 and 9 am) and in the evening (beginning between 5 and 6 pm). The time of the first appointment (first testing in the evening or morning) was randomly assigned to the patient group an 1:1 matched controls were assigned to the same order as their RLS counterpart. The time between the two appointments was maximal one week to make sure that the individual performance variation between two appointments could only marginally be affected by disease progression. Four controls had to be excluded due to data quality problems. In total, the data of 33 patients (age: 65.21 ± 1.78, 25 female, 19 patients had their first appointment in the morning) and 29 controls (age: 64.41 ± 1.60, 22 female, 18 controls had their first appointment in the morning) were analyzed. Of note, we made efforts to balance the order of appointments so that daytime effects would not be confounded with learning effects. *n* = 25 or 75.8% of RLS subjects were under dopaminergic treatment with Levodopa or dopamine agonists. Dopaminergic medication was discontinued at least 24 h prior to each appointment to minimize effects of the medication. Given that all of the patients took their RLS-medication only in the evening, they typically took the last dosage about 36 h prior to the morning appointment and at about 24 h prior to their evening appointments. For prolonged release medication like L-Dopa/benserazide retarde or rotigotine patches, we asked the patients to abstain from using them for at least 24 h prior to each appointment. Due to compliance issues and patient safety, no RLS patient was asked to abstain from their RLS medication for \> 3 days. The *n* = 8 or 24.2% of the patients who took opioids or antidepressants, were not to discontinue during the study due to safety reasons. Patients who took benzodiazepines were not included in this study to avoid potential confounding by manipulations of other neurotransmitter systems that are potentially involved in RLS ([@bb0525]). RLS patients that reported ever having experienced RLS symptoms before noon, or reported RLS symptoms during the morning appointment indicating treatment-related augmentation were excluded from the study. The study was approved by the institutional review board of the Medical faculty of the TU Dresden in Germany (EK 27012014) and conducted in accordance with the declaration of Helsinki. All participants received a reimbursement of 60 € for taking part in the study.

2.2. Questionnaires and neuropsychological assessment {#s0020}
-----------------------------------------------------

The International RLS Study Group RLS Rating Scale (IRLS) was used to measure the severity of RLS symptoms ([@bb0500]) in patients. All participants were required to complete the Beck Depression Inventory (BDI) ([@bb0045]) and the fatigue scale for motor and cognitive functions (FSMC) ([@bb0355]). A self-assessment Morningness-Eveningness questionnaire (MEQ) was used to evaluate inter-individual differences in the circadian rhythms ([@bb0240]). In addition, sleep duration and sleep quality prior to each appointment were rated by participants. Sleep quality was rated by means of a three-level Likert item ("poor", "moderate", "good" with a distributed value of − 1, 0, and 1, respectively). This study\'s neuropsychological battery included the following tests: 1). Verbal learning and memory retention test (VLMT) involving immediate retention and long-term verbal memory (C. [@bb0220]) 2) Test d2-Revision ([@bb0095]) assessing selective and sustained attention. 3) The stroop color and word test determining the individual\'s cognitive flexibility ([@bb0245]). 4) Benton visual retention test assessing visual perception and visual memory ([@bb0050]).

2.3. EEG task {#s0025}
-------------

To measure attentional and conflict monitoring processing, a flanker task ([@bb0280]) was applied. In this task, three vertically arranged stimuli were presented. The target stimulus (arrowhead) was presented in the center pointing either to the left or right. It was flanked by two adjacent, vertically aligned arrowheads (one above and one below the target) that pointed either in the same (compatible) or in the opposite (incompatible) direction as the target (see [Fig. 1](#f0005){ref-type="fig"}). The subjects had to determine the direction of the target stimulus (the central arrowhead) by pressing the left and right Ctrl buttons on a regular computer keyboard using their left and right index fingers. Compatible (75%) and incompatible stimuli (25%) were presented randomly. To exert time pressure, a warning tone was presented if the subjects did not respond within 450 ms. The flankers preceded the target by 200 ms. The target was then presented for 300 ms and simultaneously switched off together with the flankers. A fixation cross was presented at the center of the screen during the response-stimulus interval, which was randomly varied between 900 and 1300 ms. The experiment consisted of 384 trials divided into 4 equally sized blocks. Participants were encouraged to respond as quickly and accurately as possible.Fig. 1Experimental paradigm. Each trial began with the presentation of two flanker stimuli both pointing either to the left or right. After 200 ms, the target-stimulus was then presented in the center for 300 ms and simultaneously switched off together with the flankers. Flankers and target pointed either in the same (compatible) or in the opposite (incompatible) direction. The subjects had to determine the direction of the target-stimulus (the central arrowhead) by pressing the left and right Ctrl-buttons. Compatible (75%) and incompatible stimuli (25%) were presented randomly. The response-stimulus interval was randomly varied between 900 and 1300 ms.Fig. 1

2.4. EEG recording and analysis {#s0030}
-------------------------------

The EEG was recorded from 60 Ag--AgCl electrodes at equidistant positions with a sampling rate of 500 Hz. The reference electrode was located at Fpz and the ground electrode was located at θ = 58, ф = 78. Electrode impedances were kept below 5 kΩ. The recorded data were down-sampled off-line to 256 Hz using spline interpolation and a band-pass filter from 0.5 to 20 Hz with a slope of 48 db/oct each was applied. A manual raw data inspection was implemented to remove technical artifacts and irregular facial movement artifacts, while periodically occurring artifacts such as pulse artifacts, horizontal and vertical eye movements were subsequently detected and corrected using an independent component analysis (ICA; infomax algorithm). Afterwards, flanker-locked segments of trials with correct responses were separately formed for all conditions. Segments started 200 ms prior to the locking point (flanker onset) and ended 1200 ms thereafter. Next, an automated artifact rejection procedure was applied to remove all the segments the amplitudes of which were below − 100 μV or above 100 μV, or which had value differences of \> 200 μV in a 200 ms interval, or \< 0.5 μV in a 100 ms interval. After that, a current source density (CSD) transformation was applied to eliminate the reference potential from the data ([@bb0360]). Aside from eliminating the reference potential, the CSD transformation is known to serve as a spatial filter ([@bb0340]), which attenuates possible effects of volume conduction ([@bb0130], [@bb0485]) and helps to identify electrodes best reflecting different ERPs ([@bb0340], [@bb0445]). A baseline correction was then set to a time interval from − 200 ms to 0 ms before the segments were separately averaged for each condition. After that, electrodes P7, P8, P9, P10, Cz, PO1, and PO2 were selected on the basis of the scalp topography of the different ERP components. All ERP components were quantified by extracting the mean amplitude of brief time intervals centered around the respective peaks. The P1 and N1 ERPs were quantified at electrodes P7, P8, P9 and P10 following the flanker (P1: 90--100 ms; N1: 155--170 ms) and following the target stimulus (P1: 310--320 ms; N1: 400--430 ms). At electrode Cz, the N2 ERPs were quantified by extracting the mean amplitude of the time interval from 520 ms to 550 ms. At electrodes PO1 and PO2, the P3 ERPs were quantified by using the time interval from 510 ms to 540 ms. All ERP components were quantified relative to the baseline. The choice of electrodes was statistically validated using the method used by Mückschel et al. ([@bb0315]). This procedure revealed the same electrodes as identified by visual inspection.

To identify functional neuroanatomical structures that are (differentially) modulated by daytime effects and the experimental conditions in RLS patients, we used sLORETA (standardized low resolution brain electromagnetic tomography) ([@bb0345]). sLORETA reveals high convergence with fMRI data and neuronavigated EEG/TMS studies, which underlines the validity of the sources estimated using sLORETA ([@bb0145], [@bb0415]). sLORETA gives a single linear solution to the inverse problem based on extra-cranial measurements without a localization bias ([@bb0345], [@bb0415]). For sLORETA, the intracerebral volume is partitioned into 6239 voxels at 5 mm spatial resolution. The standardized current density at each voxel is calculated in a realistic head model ([@bb0185]) using the MNI152 template ([@bb0300]). In this study, the voxel-based sLORETA images were compared between patients and controls using the sLORETA-built-in voxel-wise randomization tests with 2000 permutations, based on statistical nonparametric mapping (SnPM). Voxels with significant differences (*p* \< 0.01, corrected for multiple comparisons) between contrasted conditions were located in the MNI-brain.

2.5. Statistical analysis {#s0035}
-------------------------

Independent *t*-tests were used to compare psychometric scores of patients and controls (BDI, MEQ, FSMC, sleep duration and quality). Data assessed by the neuropsychological battery and behavioral as well as neurophysiological data of the EEG task were analyzed using separate mixed effects ANOVAs comprising the within-subject factors daytime (morning vs. evening), condition (compatible vs. incompatible -- wherever applicable), and electrode (wherever applicable). Group (patients vs. controls) and first appointment (participants whose first appointment was in the morning vs. in the evening) were used as between-subjects factors. Separate ANOVAs were calculated for each behavioral and neurophysiological measure. Greenhouse--Geisser correction was applied whenever necessary. Values are provided as means ± SEMs. Post-hoc tests were Bonferroni-corrected whenever necessary.

3. Results {#s0040}
==========

We compared the behavioral and neurophysiological data obtained from our flanker task between RLS patients and healthy controls to investigate which cognitive processes and their underlying neurophysiological mechanisms were impaired in RLS patients. Since our focus was on group differences, we report all effects, which did not include the group factor (i.e. group-unrelated main effects and interactions) in the supplement (see supporting information).

3.1. Questionnaires and neuropsychological assessment {#s0045}
-----------------------------------------------------

Clinical characteristics of the patients including the neuropsychological data are shown in [Table 1](#t0005){ref-type="table"}.Table 1subject characteristics, neuropsychological scores for RLS patients and controls, and *p*-value for group comparision.Table 1RLS\
(*n* = 33)Control\
(*n* = 29)Group difference\
(*P*-value)Age65.21 ± 1.7864.41 ± 1.60First appointment\
(In the morning %)57.6%62.1%Sex (Female %)75.8%75.9%RLS medicationLevodopa, Pramipexol, Ropinirol, RotigotinIRLS26.42 ± 1.24\
(severe RLS symptoms)Sleep duration (hour)5.61 ± 0.257.03 ± 0.15*p* \< 0.001Sleep quality0.00 ± 0.100.67 ± 0.09*p* \< 0.001BDI11.14 ± 1.434.13 ± 0.71*p* \< 0.001FSMC (total)52.39 ± 3.0231.93 ± 2.00*p* \< 0.001FSMC (cognitive)26.31 ± 1.5415.07 ± 0.96*p* \< 0.001FSMC (motoric)26.09 ± 1.6516.86 ± 1.10*p* \< 0.001MEQ60.44 ± 1.3858.68 ± 2.25*p* = 0.494Stroop word (msec)14.90 ± 0.4614.86 ± 0.49*p* = 0.957Stroop color (msec)20.84 ± 0.5621.03 ± 0.60*p* = 0.819Stroop conflict (msec)41.49 ± 2.2437.10 ± 2.40*p* = 0.186d2-R123.00 ± 5.33141.01 ± 5.65*p* = 0.024Benton12.45 ± 0.2512.56 ± 0.31*p* = 0.797VLMT-reproduction\
(working memory)11.06 ± 0.3512.01 ± 0.37*p* = 0.067VLMT-reproduction\
(long-term memory)3.21 ± 0.323.15 ± 0.35*p* = 0.903VLMT-reorganization\
(long-term memory)12.46 ± 0.3212.97 ± 0.35*p* = 0.287VLMT-reproduction\
(vulnerability to interference)3.60 ± 0.353.23 ± 0.37*p* = 0.472[^2]

3.2. Behavioral data {#s0050}
--------------------

For the accuracy/errors in percent, no group-related effects were found (all F \< 3.02; all *p* \> 0.088).

For the RTs, the mixed effects ANOVA revealed an interaction effect of "daytime x condition x group" (F(1,57) = 4.62; *p* = 0.036; η^2^ = 0.075) showing that the interaction of "daytime x condition" was only found in the patient group (F(1,32) = 5.69; *p* = 0.023; η^2^ = 0.151), but not in controls (F(1,27) = 0.29; *p* = 0.595; η^2^ = 0.011). Further analyses for the patients showed that there was a larger condition difference in the evening (incompatible-compatible: 81 ms ± 6) than in the morning (incompatible-compatible: 73 ms ± 6) (t(32) = 2.39; *p* = 0.023). No other significant group-related effects were found (all F \< 3.62; all *p* \> 0.062). To rule out that the group related effects were based on motor restrictions or sleep disturbances observed in the RLS patients, we calculated correlations between IRLS scores, fatigue, sleep duration, and sleep quality of the patients with their RTs. No significant correlations were found (all \| r \| \< 0.30, all *p* \> 0.084; Bonferroni-corrected significance threshold here is *p* = 0.006). Regarding the neuropsychological test, group differences were only found in the d2-R test (see [Table 1](#t0005){ref-type="table"}). Interestingly, the RTs in the flanker task were significantly correlated with the d2-R performance scores. Participants who had higher scores in the d2-R test also responded faster in the flanker task (*r* = − 0.331, *p* = 0.010). Taken together, only RLS patients showed larger RT-based condition differences (compatible vs incompatible) in the evening than in the morning.

Given that the RLS patients were receiving different types of medical treatment, which might have potentially biased their behavioral performance, we furthermore conducted a Kruskal-Wallis tests to check whether there were any differences in accuracy or RTs between different treatment types. Contrasting L-Dopa (*n* = 7), dopamine agonists (*n* = 8), multiple pharmacological treatments for RLS (*n* = 10), and no pharmacological treatment (*n* = 7). Importantly, we found no significant differences/medication effects in any of the tested behavioral measures (all *p* ≥ 0.408).

3.3. Neurophysiological data of the flanker task {#s0055}
------------------------------------------------

### 3.3.1. Early attentional processing {#s0060}

The P1 and N1 ERPs are shown in [Fig. 2](#f0010){ref-type="fig"}.Fig. 2The N1 ERP evoked by the incompatible condition at electrode P9. Time point zero denotes the onset of the flanker stimuli; the target stimulus was presented 200 ms later. The flanker-elicited N1 showed a daytime effect (evening \> morning) in the healthy controls but not in the RLS patients. The target-elicited N1 showed a significant group difference (controls \> RLS patients) in the evening but not in the morning. This daytime-related group difference was rooted in extra-striate-visual cortex (BA 18). Group difference curves calculated for morning and evening appointments are depicted below in dark (evening) and light (morning) green separately. As shown in the middle of the figure, the group difference (controls-RLS) was larger in the evening (dark green) than in the morning (light green). The time intervals used for quantification of the flanker- and target-elicited N1 are denoted in semi-transparent blue color. The mean values and standard errors of the target N1 at electrode P9 for all conditions are plotted in a bar chat. Significant comparison is pointed out with \*. For a comprehensive figure of P1 and N1 ERPs evoked by the flanker and target stimuli at all electrodes P7/P8/P9/P10 (mean value) and in all conditions (incompatible vs compatible) please refer to the supplemental material Fig. S1. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)Fig. 2

For the flanker-elicited P1 at electrodes P7/P8/P9/P10, no group-related effects were significant (all F \< 3.55; all *p* \> 0.065). For the flanker-elicited N1 at electrodes P7/P8/P9/P10, an interaction of "daytime x group" (F(1,57) = 4.50; *p* = 0.038; η^2^ = 0.073) was found. While healthy controls had a larger flanker N1 amplitude in the evening (− 41.78 μV/m^2^ ± 4.20) than in the morning (− 38.19 μV/m^2^ ± 4.06) (t(28) = − 2.09; *p* = 0.046), patients did not show such daytime effects (t(31) = 1.29; *p* = 0.208; morning: − 37.19 μV/m^2^ ± 4.28; evening: − 34.62 μV/m^2^ ± 4.03). No other group-related effects were significant (all F \< 2.17; all *p* \> 0.094).

Analyzing the target-elicited P1 at electrodes P7/P8/P9/P10, no group-related effects were significant (all F \< 2.63; all *p* \> 0.052). For the target-evoked N1 at electrodes P7/P8/P9/P10, an interaction of "daytime x group x condition x electrode" (F(3171) = 2.70; *p* = 0.047; η^2^ = 0.045) was found showing an interaction effect of "daytime x group x condition" at electrode P9 (F(1,59) = 4.44; *p* = 0.039; η^2^ = 0.070), but no interactions at other electrodes (all F \< 1.43; all *p* \> 0.237). At electrode P9, an independent *t*-test revealed that controls (− 34.52 μV/m^2^ ± 4.72) had larger target N1 amplitudes than patients (− 25.25 μV/m^2^ ± 2.72) only in the incompatible condition in the evening (t(60) = − 1.75; *p* = 0.042) (all other comparisons: all \| t \| ≤ 1.38; *p* ≥ 0.085). The sLORETA analysis revealed that this difference between the patient group and the control group in the incompatible condition in the evening was due to activity differences in the extra-striate visual cortex (BA18), where controls had a larger activation than RLS patients. No other group-related effects were significant (all F \< 3.42; all *p* \> 0.069).

### 3.3.2. Conflict processing {#s0065}

The N2 ERPs are shown in [Fig. 3](#f0015){ref-type="fig"}.Fig. 3The N2 ERP at electrode Cz (a). The N2 showed a significant daytime effect (morning \> evening). Condition difference curves (incompatible-compatible) separately calculated for controls and RLS patients in the morning as well as in the evening appointments (b). The condition differences did not vary between groups or between daytimes. The observed condition differences in RLS patients were comparable to controls in the morning as well as in the evening. The time interval used for quantification of the target-related N2 is denoted in semi-transparent blue color. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)Fig. 3

For the N2 at electrode Cz, an interaction effect of "condition x group x daytime x first appointment" (F(1,57) = 4.41; *p* = 0.040; η^2^ = 0.072) was found showing an interaction of "condition x daytime x group" among participants who had their evening appointment first (F(1,23) = 5.65; *p* = 0.026; η^2^ = 0.197), but not in participants who had their first appointment in the morning (F(1,34) = 0.41; *p* = 0.529; η^2^ = 0.012). Further analyses for the participants who had their first appointment in the evening revealed that only healthy controls had a larger target N2 in the incompatible condition (− 23.68 μV/m^2^ ± 3.92) than the compatible condition (− 14.33 μV/m^2^ ± 4.05) in the morning (at their second appointment) (t(10) = 2.99; *p* = 0.014) but not in the evening (at their first appointment) (t(10) = 1.06; *p* = 0.313). In contrast, patients did not show any condition differences in the morning (at their second appointment) (t(10) = 1.09; *p* = 0.297) or in the evening (at their first appointment) (t(10) = 0.621; *p* = 0.546) In short, only healthy controls who had their first appointment in the evening showed a condition difference (incompatible \> compatible) at their second appointment. No other significant group-related effects were revealed (all F \< 3.99; all *p* \> 0.051). For the N2, Bayesian analysis was performed to further confirm the lack of the key interaction of "daytime x group x condition". Other than regular ANOVAs, Bayesian analyses reveal the probability of the null hypothesis being true, given the observed data ([@bb0295], [@bb0495]). Given the data *D* obtained in this study, this possibility was *p*(H~0~ \| D) = 78%, which provides positive evidence for the null hypothesis holding true according to the criteria provided by Raftery ([@bb0380]).

### 3.3.3. Stimulus evaluation, response selection, and context updating {#s0070}

The P3 ERPs are shown in [Fig. 4](#f0020){ref-type="fig"}.Fig. 4The P3 ERP at electrodes PO1/PO2 (mean value) (a). The P3 revealed a significant condition effect (incompatible \< compatible). Condition difference curves (incompatible-compatible) separately calculated for controls and RLS patients in the morning as well as in the evening appointments (b). The condition differences did not vary between groups or between daytimes. The observed condition differences in RLS patients were comparable to controls both in the morning and in the evening. The time interval used for quantification of the target-associated P3 is denoted in semi-transparent blue color. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)Fig. 4

Analyzing the P3 at electrodes PO1/PO2, no group-related effects were found (all F \< 2.86; all *p* \> 0.096). For the P3, the Bayesian analysis revealed that the probability of the null hypothesis being true, given the obtained data, was *p*(H~0~ \| D) = 88%, which also supports the null hypothesis that the interaction of "daytime x group x condition" was not present ([@bb0380]).

4. Discussion {#s0075}
=============

In the current study, we examined whether and how circadian variations affect cognitive processes in RLS patients, putting a focus on the modulated neurophysiological mechanisms. Given that an essential diagnostic feature of RLS is the presence of circadian symptom variations, we hypothesized that like the motor symptoms, cognitive deficits of RLS patients might be intensified in the evening. Our behavioral data showed that the RLS patients suffered from a cognitive decline in the evening, which could not be explained by RLS severity, fatigue, or impaired sleep quality. Also, the medication of the participants did not cause any significant performance differences within the patient group. RLS patients showed larger RT differences between the incompatible and the compatible condition (i.e. a larger flanker interference effect) in the evening than in the morning while healthy controls did not display a comparable circadian variation. Based thereon, the allocation of selective attention to relevant information, conflict monitoring or response control, which were all required in the interfering task condition, could be strongly impaired among RLS patients in the evening. Besides, RTs in the flanker task were significantly correlated to performance scores of the d2-R test, in which participants were required to select relevant stimuli and to ignore distractors. As the task requirement of d2-R test is similar to that of the flanker task, in which participants were asked to focus on the target and to suppress the attention to flanker stimuli surrounding it the correlation between two task performances may provide important hint that the decreased performance of RLS patients in the evening strongly relies on attentional selection. As RLS patients did not show a general slowing of RTs in the evening, the poor performance of the patients in the evening could not result from motor restrictions or dysfunctions associated with RLS (as further underpinned by the lack of significant correlations between RLS symptom severity and behavioral measures). This interpretation is supported by our neurophysiological data, which showed that controls had a larger target N1 than the RLS patients in the incompatible condition when the task was conducted in the evening. The N1 has been reported to reflect attentional selection processes such as focusing on task-relevant stimuli ([@bb0230], [@bb0235], [@bb0285]). The smaller N1 indicates that the attentional selection processes of RLS patients were impaired in the evening. This is consistent with previous findings that attentional selection is more demanding in conflict situations where adjustments in attentional selection processes help to resolve conflicts ([@bb0090], [@bb0110]). The source localization analysis revealed that the group differences between RLS patients and controls observed in the evening resulted from smaller activation of the extra-striate visual cortex (BA18), which contributes to selecting the important and filtering out the irrelevant information ([@bb0135], [@bb0230], [@bb0260]), in RLS patients compared to controls. Furthermore, attentional impairments shown by patients in the evening were supported by the daytime-related group differences reflected by the flanker N1. A general condition-independent circadian variation was only found in the healthy controls. The controls had a larger N1 in the evening than in the morning indicating that attentional involvement was intensified to compensate reduced alertness in the evening ([@bb0085], [@bb0140]), so that the performance in the evening could still equal that of the morning. In contrast, RLS patients have seemingly failed to enhance attentional processes to achieve such compensation in the evening, ultimately resulting in worse performance in the evening than in the morning. Since there were no group differences in terms of MEQ scores (see [Table 1](#t0005){ref-type="table"}), we rejected the alternative explanation that the performance impairments of RLS patients in the evening were due to chronotype differences. It is possible that the poor cognitive performance of the RLS patients in the evening could be due to dopaminergic dysfunction ([@bb0255], [@bb0335], [@bb0420]). Matching this, studies show that the early attentional processing in the extra-striate cortex can be top-down regulated by frontal cortex ([@bb0035], [@bb0230]). As striatal dopamine modulate the fontal activity through distinct cortico-basal ganglia circuits ([@bb0120], [@bb0215]), dopamine may indirectly affect the early attentional modulation. Aside from this, striatal dopamine may directly affect visual processing through possible connections with the visual cortex ([@bb0060], [@bb0425]). Dopamine is involved in regulating circadian rhythms ([@bb0150], [@bb0210], [@bb0265], [@bb0490], [@bb0505]) and the diurnal variation of dopamine is characterized by a peak in the morning and nadir in the evening ([@bb0040], [@bb0265], [@bb0505]). Given that RLS patients show greater circadian changes in CSF dopaminergic measures ([@bb0040], [@bb0155], [@bb0205]), it is well possible that this abnormality in dopamine-related circadian rhythm has an influence on attentional selection processes. A reduced D2 receptor binding has been reported among RLS patients ([@bb0305], [@bb0430], [@bb0435], [@bb0440], [@bb0465]) and blockade of D2 receptors attenuates acetylcholine efflux ([@bb0310]), which also plays an important role in the attention system ([@bb0400]). Inasmuch as the sensitivity of D2 autoreceptors is higher in darkness (evening phases) ([@bb0150]), a reduced D2 receptor binding of patients may impact the cholinergic system more intensively in the evening, resulting in the observed attentional deficits. These may emerge because of close interactions of the cholinergic and dopaminergic system. Aside from this, Choi et al. ([@bb0115]) reported a weaker anterior-posterior interregional interaction in the RLS patients, which may be caused by an alteration in gray matter ([@bb0475]) and dopaminergic dysfunction ([@bb0010]). This disturbance of interregional interactions might explain the observed activation differences in the extra-striate visual cortex and the resulting deficits in attentional selection processes.

Strikingly, unlike in other dopamine-related diseases such as Huntington disease (HD) ([@bb0060]), no disease-related modulation of the N2 and P3 components was found. On this account, it may be stated that conflict monitoring ([@bb0180]), context-updating ([@bb0365]) and stimulus-response mapping ([@bb0470], [@bb0480]) are less affected by RLS. This lack of effects was further substantiated by the bayesian analysis. Conflict monitoring is assumed to be a function of anterior cingulate cortex (ACC) ([@bb0090]) and decreased N2 amplitudes observed in HD have been attributed to ACC dysfunction ([@bb0055]). As known, striatum and frontal cortex are connected via different functional circuits. While the dorsal striatum is more strongly connected to the prefrontal cortex, the ventral striatum has stronger connections to the limbic cortex including ACC ([@bb0120], [@bb0215]). But while HD patients suffer from a degeneration of the neostriatum, RLS patients show a different pattern where decreases in D2 receptors are mainly found in dorsal striatum rather than ventral striatum ([@bb0160], [@bb0305], [@bb0465]). This may explain why conflict monitoring is less affected by RLS. Taken together, it seems that not all dopamine-regulated cognitive processes, such as later cognitive processes reflected by the N2 and P3 ([@bb0335], [@bb0365], [@bb0410]), are altered by the disorder and show daytime-dependent impairments. Instead, daytime-related cognitive impairments were restricted to attentional selection processes. Consistent with previous studies ([@bb0060], [@bb0070], [@bb0510], [@bb0515]), participants performed worse in the incompatible condition as compared to the compatible condition, which was underlined by our neurophysiological data. High salience, low attentional readiness and demand of conflict monitoring in the incompatible condition may account for the larger P1, the smaller N1, and the larger N2 in the incompatible condition ([@bb0180], [@bb0235], [@bb0270]). Inasmuch as an elevated P3 was normally observed in conditions with low frequency and with high demand on cognitive processing ([@bb0275]), the larger P3 in the compatible condition appeared counterintuitive. An explanation of this could be the overlapping of N2 and P3 time intervals. Although different activations of N2 and P3 were observed at distinct electrodes in the topography, the results of the N2 and P3 should therefore be interpreted with caution.

With respect to the medication, a few limitations should however be discussed. While the dopaminergic RLS medication was discontinued early enough to ensure that no patient was under direct effects of dopaminergic medication, patients who used opioids and antidepressants were encouraged to continue their medication for their own safety. Asking the patients to abstain from their medication for longer periods of time prior to their appointments would sure have been beneficial in case of retarded medication and dopamine agonists, but it would have drastically reduced the RLS patients\' compliance and would furthermore have caused sleep deficits which might also have affected behavioral performance. While non-parametric testing proved that there were no behavioral differences between the medication groups, the heterogeneity of the sample may still have contributed to the rather large observed variance. In this context, it also needs to be noted that general conclusions on medication-induced differences in RLS patients cannot be drawn from our data, because the subgroups were way too small/underpowered to reliably generalize the lack of differences found in our study to the entire population of RLS patients. Also, there are studies which have shown that dopaminergic medication may delay simple reaction times in patients with Parkinson\'s disease ([@bb0320], [@bb0325], [@bb0330]). We however deem it very unlikely to have had similar effects in our sample as there was no general slowing of responses in the patient group (i.e. no main effect of group in the RT analyses). Yet, further studies in larger patient cohorts and especially in non-medicated RLS patients should be conducted to further elucidate the impact of the disease itself and the impact of the RLS medication on cognitive function in these patients. Another limitation of this study is that we measured sleep disturbance of RLS patients based on self-reports. Applying objective measures can provide more objective and detailed information about sleep duration and stability as well as quantification of arousals, which is increased in RLS ([@bb0025], [@bb0520]) as well as periodic limb movements (PLMS), which occur in most RLS patients ([@bb0015], [@bb0200]). Moreover, it would be interesting the future studies to compare the cognitive performance between RLS patients with different phenotypes, pain symptoms or different comorbidities like obstructive sleep apnea (OSA).

5. Conclusion {#s0080}
=============

To the best of our knowledge, this is the first study showing circadian cognitive impairments among RLS patients. The amplification of impairments in the evening seems to be restricted to attentional selection processes within the extra-striate visual cortex. In contrast, other dopamine-regulated cognitive processes such as conflict monitoring and response selection did not show any circadian changes. This suggests that in RLS patients, daytime-related attentional deficits rely on the changed circadian dopaminergic rhythm and its close interaction to the cholinergic system as well as disturbed interregional communication.
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[^2]: **IRLS**: International RLS Rating Scale; **BDI**: Beck Depression Inventory; **FSMC**: Fatigue Scale for Motor and Cognitive functions; **MEQ**: Morningness-Eveningness Questionaire. Lower scores represent greater eveningness and higher scores represent greater morningness; **VLMT**: Verbal Learning and Memory retention Test.
